Studies by Pavel et al. [130] have shown that vascular endothelial growth factor (VEGF) and IL-8 are associated with tumor progression and may be qualified as markers of prognosis and treatment control in patients with neuroendocrine neoplasms. This evidence concerns the gene VEGFA and neuroendocrine neoplasm.